Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 Apr;9(4):341–349. doi: 10.1111/j.1365-2125.1980.tb01060.x

Pharmacological screening of new chemical entities in human subjects and methods of data handling.

T J Sullivan, A R Croft, R Hanka, S J Roberts
PMCID: PMC1429994  PMID: 7378250

Abstract

1 A system is described for screening new chemical entities in normal human subjects, which is designed to search for novel drug actions at an early stage of drug development. 2 In single (subject) blind experiments, doses are increased incrementally from one subject to next, with immediate feed-back of results from each dose. 3 As many physiological variables as possible are recorded, for which a purpose-designed apparatus system was constructed, and connected to a computer. 4 To overcome problems of inter-subject variability, the need for sensitivity, and to identify drug-related effects from the mass of data generated, a novel data management system was developed, and physiological profiles of volunteer subjects were built up to provide control data. 5 Results from a validation experiment in which isoprenaline was infused intravenously at different rates are presented and discussed.

Full text

PDF
341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chaput de Saintonge D. M., Vere D. W. Why don't doctors use cusums? Lancet. 1974 Jan 26;1(7848):120–121. doi: 10.1016/s0140-6736(74)92345-9. [DOI] [PubMed] [Google Scholar]
  2. Easley R. B., Rodbard D. Noninvasive monitoring of beta-adrenergic tone during isoproterenol infusions. Clin Pharmacol Ther. 1977 Dec;22(6):881–887. doi: 10.1002/cpt1977226881. [DOI] [PubMed] [Google Scholar]
  3. Hannington-Kiff J. G. Measurement of recovery from outpatient general anaesthesia with a simple ocular test. Br Med J. 1970 Jul 18;3(5715):132–135. doi: 10.1136/bmj.3.5715.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jackson D. M. Letter: A simple non-invasive technique for measuring cardiac contractility. Lancet. 1974 Dec 14;2(7894):1457–1457. doi: 10.1016/s0140-6736(74)90121-4. [DOI] [PubMed] [Google Scholar]
  5. Joubert P., Rivera-Calimlim L., Lasagna L. Commentary. The normal volunteer in clinical investigation: how rigid should selection criteria be? Clin Pharmacol Ther. 1975 Mar;17(3):253–257. doi: 10.1002/cpt1975173253. [DOI] [PubMed] [Google Scholar]
  6. Norris H. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology. 1971 Mar;10(21):181–191. doi: 10.1016/0028-3908(71)90039-6. [DOI] [PubMed] [Google Scholar]
  7. Phillips E. M., Woolnough M., Marinova V. M., Turner P. A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man. J Clin Pharmacol New Drugs. 1972 Apr;12(4):158–168. doi: 10.1002/j.1552-4604.1972.tb00045.x. [DOI] [PubMed] [Google Scholar]
  8. Pocock S. N. Earth-free patient monitoring. I. Principles, practice and hazards. Biomed Eng. 1972 Jan-Feb;7(1):21–passim. [PubMed] [Google Scholar]
  9. Simoons M. L., Hugenholtz P. G. Gradual changes of ECG waveform during and after exercise in normal subjects. Circulation. 1975 Oct;52(4):570–577. doi: 10.1161/01.cir.52.4.570. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES